AI-Driven Drug Discovery Achieves Milestone with Insilico Medicine’s Phase IIa Success in Treating Pulmonary Fibrosis
Insilico Medicine’s Generative AI-designed Drug ISM001-055 Shows Promising Results in Phase IIa Clinical Trials In a breakthrough for AI-powered drug discovery, Insilico Medicine announced positive Phase IIa results for its…